Adam Vogel
Boston University Medical School
Patient and animal neuroimaging has shown neurocircuit activity to be a robust translational biomarker of mental health conditions. For patients suffering from mental illness, I have developed genetic functional neurocircuitry tools to establish a discovery platform of reverse behavioral engineering of neurocircuitry in model systems. Developing therapeutics that not only engage a target in the traditional sense but also affects the neurocircuitry relevant to the behavioral/cognitive phenotype of the disorder offer significant opportunities for advancing mental health and the development of circuit specific therapeutics begins with discovery.